Literature DB >> 10774807

Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: implications for postexposure prophylaxis.

B Dietzschold1, K Morimoto, D C Hooper, J S Smith, C E Rupprecht, H Koprowski.   

Abstract

OBJECTIVES: Rabies virus variants associated with silver-haired bats (SHBRV) are responsible for most recent human rabies cases in the United States, which are not associated with a history of exposure. We compared their genotype and phenotype with those of dog rabies virus (DRV) variants, the classic cause of rabies in humans, to determine whether differences in these strains might have ramifications for therapeutic intervention, particularly vaccination.
METHODS: Eleven silver-haired bat and 8 dog rabies virus isolates were characterized by sequencing the glycoprotein gene, by assessing their ability to replicate in neuronal versus nonneuronal cultures at optimal and suboptimal temperatures, by assessing their pathogenicity in mice, and by determining the resistance of these viruses to therapeutic immunization with commercial vaccines.
RESULTS: SHBRV isolates were less genetically diverse, less neuronal cell specific, more temperature sensitive, but as pathogenic, on average, as DRV isolates. Immune protection was equivalent for SHBRV and DRV strains of similar pathogenicity.
CONCLUSIONS: SHBRV strains have unique characteristics that may explain their exceptional association with human rabies but have little bearing on their lethality in mice. The pathogenicity of a particular virus, rather than its antigenic makeup, determines the outcome of immunization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10774807

Source DB:  PubMed          Journal:  J Hum Virol        ISSN: 1090-9508


  37 in total

1.  Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection.

Authors:  Anirban Roy; Timothy W Phares; Hilary Koprowski; D Craig Hooper
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

2.  Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis.

Authors:  Shannon L Haley; Evgeni P Tzvetkov; Samantha Meuwissen; Joseph R Plummer; James P McGettigan
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

Review 3.  Characterization of conformation-specific monoclonal antibodies against rabies virus nucleoprotein.

Authors:  Yan Jiang; Yonghuang Luo; Frank Michel; Robert J Hogan; Ying He; Zhen F Fu
Journal:  Arch Virol       Date:  2010-06-04       Impact factor: 2.574

Review 4.  Perspectives in Diagnosis and Treatment of Rabies Viral Encephalitis: Insights from Pathogenesis.

Authors:  Anita Mahadevan; M S Suja; Reeta S Mani; Susarala K Shankar
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

5.  Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis.

Authors:  Wilfred E Marissen; R Arjen Kramer; Amy Rice; William C Weldon; Michael Niezgoda; Milosz Faber; Jerry W Slootstra; Rob H Meloen; Marieke Clijsters-van der Horst; Therese J Visser; Mandy Jongeneelen; Sandra Thijsse; Mark Throsby; John de Kruif; Charles E Rupprecht; Bernhard Dietzschold; Jaap Goudsmit; Alexander B H Bakker
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant.

Authors:  Samantha A Garcia; Aurore Lebrun; Rhonda B Kean; D Craig Hooper
Journal:  J Neurovirol       Date:  2018-07-09       Impact factor: 2.643

7.  T-bet Is Required for the Rapid Clearance of Attenuated Rabies Virus from Central Nervous System Tissue.

Authors:  Aurore Lebrun; Carla Portocarrero; Rhonda B Kean; Darryll A Barkhouse; Milosz Faber; D Craig Hooper
Journal:  J Immunol       Date:  2015-09-25       Impact factor: 5.422

8.  Differential expression of growth factors at the cellular level in virus-infected brain.

Authors:  Mikhail Prosniak; Anna Zborek; Gwen S Scott; Anirban Roy; Timothy W Phares; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-07       Impact factor: 11.205

Review 9.  Bispecific antibodies: Potential immunotherapies for HIV treatment.

Authors:  Giulia Fabozzi; Amarendra Pegu; Richard A Koup; Constantinos Petrovas
Journal:  Methods       Date:  2018-10-22       Impact factor: 3.608

10.  Concepts in the pathogenesis of rabies.

Authors:  Bernhard Dietzschold; Jianwei Li; Milosz Faber; Matthias Schnell
Journal:  Future Virol       Date:  2008-09       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.